These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25014464)

  • 1. [Stochastic phenomena and the tumoral process].
    Capp JP
    Med Sci (Paris); 2014; 30(6-7):693-8. PubMed ID: 25014464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stochastic gene expression, disruption of tissue averaging effects and cancer as a disease of development.
    Capp JP
    Bioessays; 2005 Dec; 27(12):1277-85. PubMed ID: 16299757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue disruption increases stochastic gene expression thus producing tumors: Cancer initiation without driver mutation.
    Capp JP
    Int J Cancer; 2017 Jun; 140(11):2408-2413. PubMed ID: 28052327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
    Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
    J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer genome sequencing: the challenges ahead.
    Heng HH
    Bioessays; 2007 Aug; 29(8):783-94. PubMed ID: 17621658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
    Kunkle B; Yoo C; Roy D
    Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic changes in cancer.
    Iacobuzio-Donahue CA
    Annu Rev Pathol; 2009; 4():229-49. PubMed ID: 18840073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population genetics perspective on the determinants of intra-tumor heterogeneity.
    Hu Z; Sun R; Curtis C
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):109-126. PubMed ID: 28274726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations and DNA repair in human carcinogenesis.
    Dixon K; Kopras E
    Semin Cancer Biol; 2004 Dec; 14(6):441-8. PubMed ID: 15489137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic biomarkers for human cancer: the time is now.
    Mulero-Navarro S; Esteller M
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Master and servant: epigenetic deregulations as a cause and a consequence of cancer].
    Laget S; Defossez PA
    Med Sci (Paris); 2008; 24(8-9):725-30. PubMed ID: 18789219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro model of tumor heterogeneity resolves genetic, epigenetic, and stochastic sources of cell state variability.
    Hayford CE; Tyson DR; Robbins CJ; Frick PL; Quaranta V; Harris LA
    PLoS Biol; 2021 Jun; 19(6):e3000797. PubMed ID: 34061819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
    Wilting RH; Dannenberg JH
    Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of stem cells and cancer cells on the basis of gene expression profile stability, plasticity, and robustness: dynamical systems theory of gene expressions under cell-cell interaction explains mutational robustness of differentiated cells and suggests how cancer cells emerge.
    Kaneko K
    Bioessays; 2011 Jun; 33(6):403-13. PubMed ID: 21538414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stochastic cancer progression driven by non-clonal chromosome aberrations.
    Heng HH; Stevens JB; Liu G; Bremer SW; Ye KJ; Reddy PV; Wu GS; Wang YA; Tainsky MA; Ye CJ
    J Cell Physiol; 2006 Aug; 208(2):461-72. PubMed ID: 16688757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chromatin epigenetic modifications in cancer generation].
    Arenas-Huertero F; Recillas-Targa F
    Gac Med Mex; 2002; 138(6):547-55. PubMed ID: 12532619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stochastic gene expression stabilization as a new therapeutic strategy for cancer.
    Capp JP
    Bioessays; 2012 Mar; 34(3):170-3. PubMed ID: 22231918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.